Amin Pharmaceutical Co (XTEH:AMIN1) COGS-to-Revenue : 0.00 (As of . 20)

View and export this data going back to 1990. Start your Free Trial

What is Amin Pharmaceutical Co COGS-to-Revenue?

Amin Pharmaceutical Co's Cost of Goods Sold for the six months ended in . 20 was IRR0.00 Mil. Its Revenue for the six months ended in . 20 was IRR0.00 Mil.

Amin Pharmaceutical Co's COGS to Revenue for the six months ended in . 20 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Amin Pharmaceutical Co's Gross Margin % for the six months ended in . 20 was N/A%.

Amin Pharmaceutical Co COGS-to-Revenue Historical Data

The historical data trend for Amin Pharmaceutical Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amin Pharmaceutical Co COGS-to-Revenue Chart

Amin Pharmaceutical Co Annual Data

Trend

COGS-to-Revenue

Amin Pharmaceutical Co Semi-Annual Data

COGS-to-Revenue

Amin Pharmaceutical Co COGS-to-Revenue Calculation

Amin Pharmaceutical Co's COGS to Revenue for the fiscal year that ended in . 20 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=		/
	=

Amin Pharmaceutical Co's COGS to Revenue for the quarter that ended in . 20 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=		/
	=

Amin Pharmaceutical Co (XTEH:AMIN1) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Amin Pharmaceutical Co's Gross Margin % for the six months ended in . 20 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	/
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Amin Pharmaceutical Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Amin Pharmaceutical Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Amin Pharmaceutical Co (XTEH:AMIN1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amin Pharmaceutical Co (XTEH:AMIN1) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Abolfazl Street, Bostan Heftam West Alley, No. 4, 2nd floor, Marzdaran, Tehran, IRN

Website

https://www.aminpharma.com

Amin Pharmaceutical Co is engaged in the manufacturing of pharmaceutical products, chemical drugs, herbal medicines, and nutritional supplements. It offers antimicrobials, cardiovascular, antidiabetic, cerebellar, gastrointestinal, antibiotic and antifungal, and hypoglycemic agents among others. It develops drugs in the form of plain and overlaid tablets, hard, and soft capsules, oral drops, syrups, and suspensions. Products offered by the company include Acarbose, Sitagliptin, Fampridine, Ofloxacin, Amiodarone, Ibuprofen, Zolpidem, Bilberry, Thyme, and others. Amin also exports its products to Afghanistan, Kazakhstan, Uzbekistan, and Iraq.

Amin Pharmaceutical Co (XTEH:AMIN1) Headlines

No Headlines